Navigation Links
Tailored Therapy May Help More Stop Smoking
Date:4/20/2010

People who metabolize nicotine slowly may need to wear nicotine patch longer, researchers say

TUESDAY, April 20 (HealthDay News) -- New research suggests that a set length of time for using the nicotine patch may not work for all smokers trying to kick the habit.

Researchers at the University of Pennsylvania School of Medicine have already discovered that some people -- about three-quarters of smokers -- break down (metabolize) nicotine more quickly from the patches than other people do. These people may do better by taking drugs like bupropion (Zyban).

And in the new study, researchers found that people who metabolized nicotine slowly did better if they used the nicotine patch for six months compared to slow metabolizers who were placed on the patch for only two months, followed by six months on a placebo (dummy) patch.

After six months there was no difference between the two groups.

While extended therapy helps people stay off tobacco and recover from lapses, "it only works as long as people are on it," noted Caryn Lerman, deputy director of the Abramson Cancer Center at the University of Pennsylvania, in a press release. "Those data lead to the compelling question of whether some smokers should be on nicotine patch therapy for the long term."

She said some patients may need to take treatment longer than the current recommended standard of two months.

The study is scheduled for release Tuesday at the American Association of Cancer Research's annual meeting in Washington D.C.

More information

The U.S. National Library of Medicine has more about quitting smoking.



-- Randy Dotinga



SOURCE: University of Pennsylvania School of Medicine, press release, April 20, 2010. <
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Targeted therapy prolongs life in patients with HER2-positive breast cancer
2. PharmMD Secures Investments to Fund New Opportunities in Medication Therapy Management
3. More smokers kick the habit with extended nicotine patch therapy, Penn research shows
4. Experts Issue Warning on Prostate Hormone Therapy
5. ASGCT: Gene Therapy Shows Promise for Patients with Pompe Disease
6. AAPM statement on quality radiation therapy
7. Congress Urged to Take Immediate Action to Ensure Frail Patients Continue to Receive Critical Therapy Services
8. Intensive Insulin Therapy Wont Boost Septic Shock Survival
9. News brief: Dermatologic infections in cancer patients treated with EGFRI therapy
10. A new target for lymphoma therapy
11. NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... British researchers report that an alternative to the traditional ... their experiments, the scientists found that clasping hands transferred ... the other than what is known as a fist ... as a cultural substitute for the firm gripping of ... issue of the American Journal of Infection Control ...
(Date:7/28/2014)... do not divide unless there is enough oxygen present ... other cell types circumvent this rule. Researchers at The ... overrides the cells, warning signals, enabling cancers to continue ... the process, the researchers found that lysosomes the ... decisions. They also uncovered new evidence that certain drugs ...
(Date:7/28/2014)... Michigan (PRWEB) July 28, 2014 The ... Drs. Harris, Birkhill, Wang, Songe and Associates, PC that ... and countless tomorrows to come. , The HBWS ... responsible for more than $2.5 million in donations. Through ... title sponsors for the Oakwood Women’s Healthcare Classic for ...
(Date:7/28/2014)... Lake City, Utah (PRWEB) July 28, 2014 ... protein powders and drinks, announced that it will be ... drink line of products this summer. The additional flavors ... with clean pure taste-free protein , Inspire Pomegranate Razz ... Vanilla - flavor of soft-serve vanilla cone , Bariatric ...
(Date:7/28/2014)... UT Southwestern Medical Center cancer researchers have found ... the activity of a mutated cancer gene common ... SML-8-73-1 (SML), interferes with the KRAS gene, or ... produces proteins called K-Ras that influence when cells ... cells dividing uncontrollably and turning cancerous. These ...
Breaking Medicine News(10 mins):Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3Health News:Cell's recycling center implicated in division decisions 2Health News:Bariatric Eating Announces Three New Protein Shake Flavors 2Health News:UTSW cancer researchers identify irreversible inhibitor for KRAS gene mutation 2
... 2011. Researchers from the University of Maryland School of Medicine ... of exercise and computerized memory training to see if those ... The type of memory that will be examined is known ... and use it in a new way. Many ...
... (DECEMBER 12, 2011) Autism Speaks North America,s ... National Institutes of Health (NIH) in announcing the addition ... a data federation site for the National Database for ... will help create the largest multidisciplinary source of autism ...
... and lethal of all human brain tumors that originate ... followed by both radiation therapy and chemotherapy with temozolomide. ... temozolomide. A team of researchers led by Sameer Agnihotri, ... that the protein APNG can contribute to GBM resistance ...
... - Researchers from Boston University School of Medicine (BUSM) ... receptor (A2bAR) as a possible new therapeutic target against ... cholesterol. The findings, which appear on-line in Circulation ... is a metabolite produced naturally by cells at low ...
... New research from the laboratory of Dr. Elizabeth Leadbetter at ... of vaccines. Dr. Leadbetter,s lab has discovered new properties of ... for enhancing protection against a number of different infections. This ... of the journal Nature Immunology (Vol. 13, pp. ...
... by blocking the export of key control molecules from ... treatment for chronic lymphocytic leukemia (CLL) and other incurable ... at the Ohio State University Comprehensive Cancer Center ... Research Institute (OSUCCC James)., The agent, called KPT-SINE, ...
Cached Medicine News:Health News:Exercise/memory research for Parkinson's 2Health News:Exercise/memory research for Parkinson's 3Health News:Autism Speaks Autism Genetic Resource Exchange joins NIH National Database for Autism Research 2Health News:Autism Speaks Autism Genetic Resource Exchange joins NIH National Database for Autism Research 3Health News:Researchers identify agent responsible for protection against early stages of atherosclerosis 2Health News:Trudeau Institute announces latest discovery in vaccine development 2Health News:Trudeau Institute announces latest discovery in vaccine development 3Health News:Novel export-inhibitor shows promise for treating CLL 2
(Date:7/28/2014)... 2014  MiMedx Group, Inc. (NASDAQ: MDXG ), an ... and bioimplants processed from human amniotic membrane, announced today its ... Highlights include: , Revenue exceeds upper end ... $25.6 million , Quarter-over-quarter revenue grew ... increases 181% over Q2 2013 and 40% sequentially over Q1 ...
(Date:7/28/2014)... , July 28, 2014   Stone & ... of off-label marketing and fraud claims between the ... Solutions, Inc. ("VSI").  The settlement covers fraud in ... for endovenous laser ablation of varicose veins for ... firm with a history of representing whistleblowers in ...
(Date:7/28/2014)... , July 28, 2014 /PRNewswire-iReach/ -- June 28 th , ... which has developed the AMAS cancer test, is making its ... To date, the test, which is a serum-based in vitro ... emerging as a significant tool in the fight against cancer ... With an estimated 17 million cancer survivors in the ...
Breaking Medicine Technology:MiMedx Announces Record Second Quarter Results 2MiMedx Announces Record Second Quarter Results 3MiMedx Announces Record Second Quarter Results 4MiMedx Announces Record Second Quarter Results 5MiMedx Announces Record Second Quarter Results 6MiMedx Announces Record Second Quarter Results 7MiMedx Announces Record Second Quarter Results 8MiMedx Announces Record Second Quarter Results 9MiMedx Announces Record Second Quarter Results 10MiMedx Announces Record Second Quarter Results 11MiMedx Announces Record Second Quarter Results 12MiMedx Announces Record Second Quarter Results 13MiMedx Announces Record Second Quarter Results 14MiMedx Announces Record Second Quarter Results 15MiMedx Announces Record Second Quarter Results 16MiMedx Announces Record Second Quarter Results 17MiMedx Announces Record Second Quarter Results 18Stone & Magnanini LLP Announces $520,000 Department of Justice False Claims Act Settlement With Vascular Solutions, Inc. 2Stone & Magnanini LLP Announces $520,000 Department of Justice False Claims Act Settlement With Vascular Solutions, Inc. 3Oncolab, Inc. Exhibits Pioneering AMAS Cancer Test at AACC 2
... safety profile of BSI-201 in ... subjects with advanced solid tumors -, BRISBANE, Calif., ... developing novel cancer therapies,today announced that data supporting its lead ... of Clinical Oncology annual,meeting in Chicago., Findings will be ...
... SGP ), a leader in advancing the ... infection, announced today that data from,several clinical studies ... therapy, as well as boceprevir, the,company,s investigational oral ... annual Digestive Disease Week (DDW) meeting to be ...
Cached Medicine Technology:BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7
The LIGACLIP ERCA Endoscopic Rotating Multiple Clip Applier is intended for use on tubular structures or vessels wherever a metal ligating clip is indicated. The tissue being ligated should be consis...
... The LIGACLIP 20/20 Multiple Clip Applier is ... medium clips. This automatic instrument is preloaded ... each firing by means of the unique ... Clip Applier is reloadable once with a ...
... places one staple each time the instrument handles ... and are then formed, thus holding the tissue ... sizes: wide (having a clip span of 13.0 ... span of 9.9 mm before closure). The skin ...
... The Autosuture MULTIFIRE PREMIUM skin ... time the instrument handle is ... the skin and is then ... together. There are different sizes ...
Medicine Products: